LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
78 hedge funds and large institutions have $283M invested in LYRA THERAPEUTICS INC in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 29 increasing their positions, 12 reducing their positions, and 7 closing their positions.
23,225% more call options, than puts
Call options by funds: $1.87M | Put options by funds: $8K
257% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 7
142% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 12
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
30% more funds holding
Funds holding: 60 → 78 (+18)
28% more capital invested
Capital invested by funds: $222M → $283M (+$61.4M)
0.09% less ownership
Funds ownership: 1.61% → 1.53% (-0.09%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$7.88M |
| 2 |
ABG
Ally Bridge Group
New York
|
+$5.35M |
| 3 |
TLP
Tri Locum Partners
New York
|
+$5.22M |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$4.09M |
| 5 |
LCM
Laurion Capital Management
New York
|
+$3.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VPC
Vestal Point Capital
New York
|
-$11.7M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$6.55M |
| 3 |
AC
Armistice Capital
New York
|
-$5.7M |
| 4 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$3.97M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.37M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
National Bank of Canada
Montreal,
Quebec, Canada
| $1.39K | +$19.7K | +74 | New |
|
77
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $622 | +$533 | +2 | New |
|
78
UBS Group
Zurich,
Switzerland
| $112 | -$25.6K | -96 | Closed |
|
79
Macquarie Group
Sydney, NSW 2000,
Australia
| $9 | +$7.46K | +28 | New |
|
|
AC
80
Armistice Capital
New York
| – | -$5.7M | -21,760 | Closed |
|
|
6CM
81
683 Capital Management
New York
| – | -$366K | -1,397 | Closed |
|
82
Bank of New York Mellon
New York
| – | -$97.6K | -372 | Closed |
|
|
TSS
83
Two Sigma Securities
New York
| – | -$66.9K | -255 | Closed |
|
84
Simplex Trading
Chicago,
Illinois
| – | -$6.13K | -23 | Closed |
|
85
Group One Trading
Chicago,
Illinois
| – | -$1.05K | -4 | Closed |
|
LYRA Hedge Fund Activity: Q1 2024 in Review
78 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q1 2024, worth a combined $283M — up 28% from $222M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new LYRA positions and 7 closed out — a net gain of 18 holders — while 29 added to existing stakes and 12 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $7.88M. The largest seller was Vestal Point Capital, cutting an estimated $11.7M.
- 78 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q1 2024, up from 60 in Q4 2023.
- Funds reported $283M of LYRA THERAPEUTICS INC stock for Q1 2024, up 28% quarter-over-quarter.
- 25 funds opened new LYRA THERAPEUTICS INC positions in Q1 2024 and 7 closed out, a net change of +18 holders.
- The largest LYRA THERAPEUTICS INC buyer in Q1 2024 was Citadel Advisors, an estimated $7.88M added.
- The largest LYRA THERAPEUTICS INC seller in Q1 2024 was Vestal Point Capital, an estimated $11.7M sold.
Based on aggregated 13F filings for Q1 2024.